Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT00353418
Status:
COMPLETED
Last Update Posted:
2010-08-03
First Post:
2006-07-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-17
First Submit QC Date:
None
Study First Post Date:
2006-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-05-14
Results First Submit QC Date:
None
Results First Post Date:
2010-06-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-07-30
Last Update Post Date:
2010-08-03
Last Update Post Date Type:
ESTIMATED